(Q45800418)

16 December 2017

reason for preferred rank

title

Human monoclonal autoimmune antibody producedin Vitro: rheumatoid factor generated by Epstein-Barr virus-transformed cell line (English)

1 reference

https://api.crossref.org/works/10.1002/EJI.1830120206

15 September 2023

Human monoclonal autoimmune antibody produced in vitro: rheumatoid factor generated by Epstein-Barr virus-transformed cell line (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6281026

15 September 2023

0 references

1 reference

https://api.crossref.org/works/10.1002/EJI.1830120206

15 September 2023

Steinitz M

1 reference

16 December 2017

Tamir S

series ordinal

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 February 1982

1 reference

16 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.1830120206

1 reference

https://api.crossref.org/works/10.1002/EJI.1830120206

https://onlinelibrary.wiley.com/doi/full/10.1002/eji.1830120206

15 September 2023

1 reference

https://api.crossref.org/works/10.1002/EJI.1830120206

European Journal of Immunology

15 September 2023

published in

1 reference

16 December 2017

volume

1 reference

16 December 2017

issue

1 reference

16 December 2017

page(s)

126-133

1 reference

16 December 2017

Superinfection of EBV-carrying lines with Herpes virus papio (HVP): Induction of early antigen (EA) and inhibition of cellular DNA synthesis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

Release of infectious Epstein-Barr virus by transformed marmoset leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

EB virus-induced B lymphocyte cell lines producing specific antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Establishment of Anti-TNP Antibody-producing Human Lymphoid Lines by Preselection for Hapten Binding followed by EBV Transformation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Hidden rheumatoid factors with specificity for native gamma globulins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Continuous production of monoclonal rheumatoid factor by EBV-transformed lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

The chromic chloride method of coupling antigens to erythrocytes: Definition of some important parameters

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

A plaque assay for all cells secreting Ig of a given type or class

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Significance of protein a production by staphylococci

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Establishment in continuous culture of a T-lymphoid cell line (HD-Mar) from a patient with Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Immunochemical quantitation of antigens by single radial immunodiffusion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Interaction of aggregated -globulin with B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Classification and biological nature of established human hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. I. Complement receptor distribution and complement binding by separated lymphocyte subpopulations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Production of Antibody to Tetanus Toxoid by Continuous Human Lymphoblastoid Cell Lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Human lymphoblastoid cell line producing specific antibody against Rh-antigen D

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Production of Human IgM Anti-D in Tissue Culture by EB-Virus-transformed Lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Production of human hybridomas secreting antibodies to measles virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Determination of immunoglobulin classes of specific antibodies secreted by single cells. A cluster formation assay.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Complement fixation by rheumatoid factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Influence of the alternative protein A interaction on the precipitation between human monoclonal immunoglobulins and protein A from Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120206

7 January 2021

1300

Klein

1968

1 reference

https://api.crossref.org/works/10.1002/EJI.1830120206

15 September 2023

Identifiers

1 reference

16 December 2017

1 reference

16 December 2017